Alligator Bioscience (Sweden) Performance
| ATORX Stock | SEK 0.12 0.08 193.40% |
Alligator Bioscience holds a performance score of 12 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.06, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Alligator Bioscience are expected to decrease by larger amounts. On the other hand, during market turmoil, Alligator Bioscience is expected to outperform it. Use Alligator Bioscience treynor ratio, as well as the relationship between the expected short fall and day median price , to analyze future returns on Alligator Bioscience.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Alligator Bioscience AB are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Alligator Bioscience unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 103.3 M | |
| Total Cashflows From Investing Activities | -45 K |
Alligator |
Alligator Bioscience Relative Risk vs. Return Landscape
If you would invest 4.72 in Alligator Bioscience AB on November 29, 2024 and sell it today you would earn a total of 7.28 from holding Alligator Bioscience AB or generate 154.24% return on investment over 90 days. Alligator Bioscience AB is generating 22.2739% of daily returns and assumes 138.6331% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than Alligator on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Alligator Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alligator Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Alligator Bioscience AB, and traders can use it to determine the average amount a Alligator Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1607
| Best Portfolio | Best Equity | ATORX | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 138.63 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Alligator Bioscience is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alligator Bioscience by adding it to a well-diversified portfolio.
Alligator Bioscience Fundamentals Growth
Alligator Stock prices reflect investors' perceptions of the future prospects and financial health of Alligator Bioscience, and Alligator Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alligator Stock performance.
| Return On Equity | -1.04 | |||
| Return On Asset | -0.48 | |||
| Operating Margin | (5.39) % | |||
| Current Valuation | 236.82 M | |||
| Shares Outstanding | 220.58 M | |||
| Price To Book | 2.57 X | |||
| Price To Sales | 17.76 X | |||
| Revenue | 12.94 M | |||
| EBITDA | (130.36 M) | |||
| Cash And Equivalents | 278.15 M | |||
| Cash Per Share | 4.27 X | |||
| Total Debt | 3.51 M | |||
| Debt To Equity | 5.10 % | |||
| Book Value Per Share | 0.40 X | |||
| Cash Flow From Operations | (127.03 M) | |||
| Earnings Per Share | (0.60) X | |||
| Total Asset | 333.2 M | |||
About Alligator Bioscience Performance
Assessing Alligator Bioscience's fundamental ratios provides investors with valuable insights into Alligator Bioscience's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Alligator Bioscience is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Alligator Bioscience AB develops antibody-based pharmaceuticals for cancer treatment. Alligator Bioscience AB was founded in 2001 and is headquartered in Lund, Sweden. Alligator Bioscience operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 56 people.Things to note about Alligator Bioscience performance evaluation
Checking the ongoing alerts about Alligator Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alligator Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alligator Bioscience is way too risky over 90 days horizon | |
| Alligator Bioscience has some characteristics of a very speculative penny stock | |
| Alligator Bioscience appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 12.94 M. Net Loss for the year was (141.74 M) with loss before overhead, payroll, taxes, and interest of (111.72 M). | |
| Alligator Bioscience AB has accumulated about 278.15 M in cash with (127.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 52.0% of the company shares are held by company insiders |
- Analyzing Alligator Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alligator Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Alligator Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alligator Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alligator Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alligator Bioscience's stock. These opinions can provide insight into Alligator Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Alligator Stock Analysis
When running Alligator Bioscience's price analysis, check to measure Alligator Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alligator Bioscience is operating at the current time. Most of Alligator Bioscience's value examination focuses on studying past and present price action to predict the probability of Alligator Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alligator Bioscience's price. Additionally, you may evaluate how the addition of Alligator Bioscience to your portfolios can decrease your overall portfolio volatility.